Integrating Pathogen- and Host-derived Blood Biomarkers for Enhanced Tuberculosis Diagnosis: a Comprehensive Review

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Aug 26

PMID 39185416

Authors

Zhaodong Li

Yunlong Hu

Wenfei Wang

Fa Zou

Jing Yang

Wei Gao

SiWan Feng

Guanghuan Chen

Chenyan Shi

Yi Cai

Guofang Deng

Xinchun Chen

Affiliations

Soon will be listed here.

Abstract

This review explores the evolving landscape of blood biomarkers in the diagnosis of tuberculosis (TB), focusing on biomarkers derived both from the pathogen and the host. These biomarkers provide critical insights that can improve diagnostic accuracy and timeliness, essential for effective TB management. The document highlights recent advancements in molecular techniques that have enhanced the detection and characterization of specific biomarkers. It also discusses the integration of these biomarkers into clinical practice, emphasizing their potential to revolutionize TB diagnostics by enabling more precise detection and monitoring of the disease progression. Challenges such as variability in biomarker expression and the need for standardized validation processes are addressed to ensure reliability across different populations and settings. The review calls for further research to refine these biomarkers and fully harness their potential in the fight against TB, suggesting a multidisciplinary approach to overcome existing barriers and optimize diagnostic strategies. This comprehensive analysis underscores the significance of blood biomarkers as invaluable tools in the global effort to control and eliminate TB.

References

Khaliq A, Ravindran R, Hussainy S, Krishnan V, Ambreen A, Yusuf N . Field evaluation of a blood based test for active tuberculosis in endemic settings. PLoS One. 2017; 12(4):e0173359. PMC: 5381859. DOI: 10.1371/journal.pone.0173359. View

Yang J, Han X, Liu A, Bai X, Xu C, Bao F . Use of Digital Droplet PCR to Detect DNA in Whole Blood-Derived DNA Samples from Patients with Pulmonary and Extrapulmonary Tuberculosis. Front Cell Infect Microbiol. 2017; 7:369. PMC: 5554497. DOI: 10.3389/fcimb.2017.00369. View

Meng Z, Wang M, Guo S, Zhou Y, Lyu M, Hu X . Novel Long Non-coding RNA and LASSO Prediction Model to Better Identify Pulmonary Tuberculosis: A Case-Control Study in China. Front Mol Biosci. 2021; 8:632185. PMC: 8185277. DOI: 10.3389/fmolb.2021.632185. View

Kashyap R, Nayak A, Gaherwar H, Bhullar S, Husain A, Shekhawat S . Laboratory investigations on the diagnosis of tuberculosis in the malnourished tribal population of melghat, India. PLoS One. 2013; 8(9):e74652. PMC: 3772098. DOI: 10.1371/journal.pone.0074652. View

Meier N, Sutter T, Jacobsen M, Ottenhoff T, Vogt J, Ritz N . Machine Learning Algorithms Evaluate Immune Response to Novel Antigens for Diagnosis of Tuberculosis. Front Cell Infect Microbiol. 2021; 10:594030. PMC: 7820115. DOI: 10.3389/fcimb.2020.594030. View

Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G . Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit. Int J Mycobacteriol. 2017; 5 Suppl 1:S25-S26. DOI: 10.1016/j.ijmyco.2016.09.063. View

Osei Sekyere J, Maphalala N, Malinga L, Mbelle N, Maningi N . A Comparative Evaluation of the New Genexpert MTB/RIF Ultra and other Rapid Diagnostic Assays for Detecting Tuberculosis in Pulmonary and Extra Pulmonary Specimens. Sci Rep. 2019; 9(1):16587. PMC: 6851384. DOI: 10.1038/s41598-019-53086-5. View

Hur Y, Kang Y, Jang S, Hong J, Kim A, Lee S . Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects. J Infect. 2014; 70(4):346-55. DOI: 10.1016/j.jinf.2014.10.019. View

Levinson T, Wasserman A . C-Reactive Protein Velocity (CRPv) as a New Biomarker for the Early Detection of Acute Infection/Inflammation. Int J Mol Sci. 2022; 23(15). PMC: 9330915. DOI: 10.3390/ijms23158100. View

10.

Kumar N, Hissar S, Thiruvengadam K, Banurekha V, Suresh N, Shankar J . Discovery and Validation of a Three-Cytokine Plasma Signature as a Biomarker for Diagnosis of Pediatric Tuberculosis. Front Immunol. 2021; 12:653898. PMC: 8085486. DOI: 10.3389/fimmu.2021.653898. View

11.

Huang Z, LaCourse S, Kay A, Stern J, Escudero J, Youngquist B . CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study. Lancet Microbe. 2022; 3(7):e482-e492. PMC: 9300929. DOI: 10.1016/S2666-5247(22)00087-8. View

12.

Takenami I, de Oliveira C, Lima F, Soares J, Machado Jr A, Riley L . Immunoglobulin G response to mammalian cell entry 1A (Mce1A) protein as biomarker of active tuberculosis. Tuberculosis (Edinb). 2016; 100:82-88. DOI: 10.1016/j.tube.2016.07.012. View

13.

Harries A, Kumar A . Challenges and Progress with Diagnosing Pulmonary Tuberculosis in Low- and Middle-Income Countries. Diagnostics (Basel). 2018; 8(4). PMC: 6315832. DOI: 10.3390/diagnostics8040078. View

14.

Huang H, Chen Y, Zuo J, Deng C, Fan J, Bai L . MXene-incorporated CNPs and Au@Pt with dual-electric signal outputs for accurate detection of Mycobacterium tuberculosis ESAT-6 antigen. Biosens Bioelectron. 2023; 242:115734. DOI: 10.1016/j.bios.2023.115734. View

15.

Melkie S, Arias L, Farroni C, Makek M, Goletti D, Vilaplana C . The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group. Eur Respir Rev. 2022; 31(163). PMC: 9489037. DOI: 10.1183/16000617.0218-2021. View

16.

La Manna M, Orlando V, Li Donni P, Sireci G, Di Carlo P, Cascio A . Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease. PLoS One. 2018; 13(3):e0192664. PMC: 5854242. DOI: 10.1371/journal.pone.0192664. View

17.

Migliori G, Tiberi S . WHO drug-resistant TB guidelines 2022: what is new?. Int J Tuberc Lung Dis. 2022; 26(7):590-591. DOI: 10.5588/ijtld.22.0263. View

18.

Wang L, Xie B, Zhang P, Ge Y, Wang Y, Zhang D . LOC152742 as a biomarker in the diagnosis of pulmonary tuberculosis infection. J Cell Biochem. 2019; 120(6):8949-8955. DOI: 10.1002/jcb.27452. View

19.

Li Q, Ren W, Yuan J, Guo H, Shang Y, Wang W . Significant difference in Th1/Th2 paradigm induced by tuberculosis-specific antigens between IGRA-positive and IGRA-negative patients. Front Immunol. 2022; 13:904308. PMC: 9471257. DOI: 10.3389/fimmu.2022.904308. View

20.

Kobashi Y, Shimizu H, Ohue Y, Mouri K, Obase Y, Miyashita N . Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis. Lung. 2010; 188(4):283-7. PMC: 2899021. DOI: 10.1007/s00408-010-9238-3. View